348 (PB336): ATRN-119, a Novel Macrocyclic ATR Inhibitor, in Patients with Advanced Solid Malignancies: A Phase 1/2a Trial (ABOYA-119)

A. Mahipal,P. LoRusso, R. Schneider, C. Miller,D. Stenehjem, J. Gullbo, E. Brown, M. Carleton, N. Mirza,F. Simpkins

European Journal of Cancer（2024）

Cited 0|Views1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined